Anaplastic lymphoma kinase gene mutation Clinical Trials
Conditions / Anaplastic lymphoma kinase gene mutation
Delta Trials records 2 clinical trials for Anaplastic lymphoma kinase gene mutation in its publicly accessible dataset. From the full dataset, 1 actively seeking eligible participants and 1 trial have reached completion. This research is conducted across 60 study locations around the world. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
2
Total Trials
1
Recruiting
1
Completed
0
Other Active
0
Terminated since 2020
60
Study Locations
Browse by location (60 total)
- Villejuif, France 2 trialsAll trials in Villejuif, France
- Colmar, France 1 trialAll trials in Colmar, France
- Dole, France 1 trialAll trials in Dole, France
- Nice, France 1 trialAll trials in Nice, France
- Vannes, France 1 trialAll trials in Vannes, France
- Pau, France 1 trialAll trials in Pau, France
- Saint-Priest-en-Jarez, France 1 trialAll trials in Saint-Priest-en-Jarez, France
- Saint-Priest-en-Jarez, France 1 trialAll trials in Saint-Priest-en-Jarez, France
- Dijon, France 1 trialAll trials in Dijon, France
- Toulouse, France 1 trialAll trials in Toulouse, France
- Villefranche, France 1 trialAll trials in Villefranche, France
- Angers, France 1 trialAll trials in Angers, France
- Bordeaux, France 1 trialAll trials in Bordeaux, France
- Clermont-Ferrand, France 1 trialAll trials in Clermont-Ferrand, France
- Brest, France 1 trialAll trials in Brest, France
- Leiden, Netherlands 1 trialAll trials in Leiden, Netherlands
- Mâcon, France 1 trialAll trials in Mâcon, France
- Rodez, France 1 trialAll trials in Rodez, France
- Fréjus, France 1 trialAll trials in Fréjus, France
- Pierre-Bénite, France 1 trialAll trials in Pierre-Bénite, France